Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies

BACKGROUND: Both intermittent intravenous (IIV) infusion and continuous intravenous (CIV) infusion of Endostar are widely used for NSCLC in China. We aimed to compare the efficacy and safety of CIV of Endostar versus IIV in combination with first-line chemotherapy for patients with advanced NSCLC. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Xu, Lu, Li, Qihuan, Man, Sailimai, Jin, Cheng, Liu, Lian, Zhan, Siyan, Ning, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579986/
https://www.ncbi.nlm.nih.gov/pubmed/33087103
http://dx.doi.org/10.1186/s12885-020-07527-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579986/
https://www.ncbi.nlm.nih.gov/pubmed/33087103
http://dx.doi.org/10.1186/s12885-020-07527-4

Ejemplares similares